Samsung Biologics Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Samsung Biologics Co Ltd

Watchlist Manager

Watchlist

Price: 1 396 000 KRW 0.94% Market Closed

Market Cap: ₩64.6T

	Samsung Biologics Co Ltd KRX:207940	KR
	Ironbark Zinc Ltd ASX:IBG	AU
A	Aurelia Metals Ltd F:YTR	AU
L	Linde PLC XHAM:LIN	UK

Profitability Summary

Samsung Biologics Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

51%

Gross Margin is Increasing

50% > 55%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

33%

Operating Margin is Increasing

32% > 45%

Exceptional Net Margin

39%

Sustainable 3Y Average Net Margin

26%

Net Margin is Increasing

24% > 39%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

4% > 17%

Positive ROE

15%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.